Published June 8, 2022
As year-three of the COVID-19 pandemic begins, global health experts have obtained increasingly more data and are digging into it to better understand how the virus will continue to impact populations around the world. That focus includes recognizing how long COVID, mental health, community health and environmental impacts are — and will continue to be — concerns for worldwide public health.
UB’s 11th Annual Global Health Day Symposium, held virtually this year, recently brought together experts from the World Health Organization (WHO), the National Institutes of Health, academia, medicine, public health and the Western New York community to share insights about the next stages of response to the pandemic.
Keynote speaker Janet Diaz, clinical head of the WHO program responsible for readiness and response to emerging infectious diseases, highlighted post-COVID conditions and patient advocacy. Even patients who were not hospitalized with COVID-19 (i.e., most patients) have persistent, burdensome symptoms months following infection, she said. Patient advocacy groups have tasked WHO with three areas to focus on in response to the issue: recognition, research and rehabilitation.
“Post COVID-19 conditions remain under-recognized, and though awareness is increasing, it is not increasing fast enough,” Diaz said. The good news is that governments are beginning to commit funds to ongoing studies, she said.
Each panelist shared their data, collection methods and findings, including:
The Global Health Day Symposium is sponsored and produced annually by UB’s Office of Global Health Initiatives.
UB Health Impact Briefs